Nanoscope Therapeutics Announces Presentations at the Americ

Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degenerations (AMD), today announced presentations at the American Academy of Ophthalmology (AAO) 2023 Annual Meeting and Eyecelerator @ AAO 2023 taking place in San Francisco, California. Details for the presentations are as follows:

Related Keywords

Samuel Barone , Francisco Marriott Marquis , Moscone Center , Nanoscope Therapeutics Inc , Session Title , San Francisco Marriott Marquis , Nob Hill , Chief Medical , Multi Characteristic Opsin , Late Breaking Developments , Live Broadcast , West Building , American Academy Of Ophthalmology , Retinal Diseases , Lao , Stargardt Disease , Gene Therapies , Nanoscope Therapeutics , Presentation ,